Show simple item record

dc.contributor.authorEveritt, AR
dc.contributor.authorClare, S
dc.contributor.authorMcDonald, JU
dc.contributor.authorKane, L
dc.contributor.authorHarcourt, K
dc.contributor.authorAhras, M
dc.contributor.authorLall, A
dc.contributor.authorHale, C
dc.contributor.authorRodgers, A
dc.contributor.authorYoung, DB
dc.contributor.authorHaque, A
dc.contributor.authorBillker, O
dc.contributor.authorTregoning, JS
dc.contributor.authorDougan, G
dc.contributor.authorKellam, P
dc.date.accessioned2021-02-04T01:51:44Z
dc.date.available2021-02-04T01:51:44Z
dc.date.issued2013-11-21
dc.identifierpii: PONE-D-13-31593
dc.identifier.citationEveritt, A. R., Clare, S., McDonald, J. U., Kane, L., Harcourt, K., Ahras, M., Lall, A., Hale, C., Rodgers, A., Young, D. B., Haque, A., Billker, O., Tregoning, J. S., Dougan, G. & Kellam, P. (2013). Defining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model. PLOS ONE, 8 (11), https://doi.org/10.1371/journal.pone.0080723.
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/11343/259499
dc.description.abstractThe interferon-inducible transmembrane (IFITM) family of proteins has been shown to restrict a broad range of viruses in vitro and in vivo by halting progress through the late endosomal pathway. Further, single nucleotide polymorphisms (SNPs) in its sequence have been linked with risk of developing severe influenza virus infections in humans. The number of viruses restricted by this host protein has continued to grow since it was first demonstrated as playing an antiviral role; all of which enter cells via the endosomal pathway. We therefore sought to test the limits of antimicrobial restriction by Ifitm3 using a knockout mouse model. We showed that Ifitm3 does not impact on the restriction or pathogenesis of bacterial (Salmonella typhimurium, Citrobacter rodentium, Mycobacterium tuberculosis) or protozoan (Plasmodium berghei) pathogens, despite in vitro evidence. However, Ifitm3 is capable of restricting respiratory syncytial virus (RSV) in vivo either through directly restricting RSV cell infection, or by exerting a previously uncharacterised function controlling disease pathogenesis. This represents the first demonstration of a virus that enters directly through the plasma membrane, without the need for the endosomal pathway, being restricted by the IFITM family; therefore further defining the role of these antiviral proteins.
dc.languageEnglish
dc.publisherPUBLIC LIBRARY SCIENCE
dc.titleDefining the Range of Pathogens Susceptible to Ifitm3 Restriction Using a Knockout Mouse Model
dc.typeJournal Article
dc.identifier.doi10.1371/journal.pone.0080723
melbourne.affiliation.departmentMicrobiology and Immunology
melbourne.affiliation.facultyCollected Works
melbourne.source.titlePLoS One
melbourne.source.volume8
melbourne.source.issue11
dc.rights.licenseCC BY
melbourne.elementsid1080627
melbourne.contributor.authorDougan, Gordon
melbourne.contributor.authorHaque, Ashraful
dc.identifier.eissn1932-6203
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record